Antitrust Antitrust

Advanz exploited lack of rivals to hike drug's price, UK regulator tells judge

By Simon Zekaria
  • 13 Oct 2022 17:45
  • 13 Oct 2022 17:45
Advanz Pharma exploited its power over a thyroid medicine market lacking any competitive pressure by raising the price dramatically, the UK competition watchdog told a judge in London today. 

The Competition and Markets Authority, which fined the drugmaker and two former parent companies last year, rejected the company’s argument that the price it

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News